Familial occurrence of thymoma and autoimmune diseases with the constitutional translocation t(14;20)(q24.1;p12.3)

Genes Chromosomes and Cancer

Volumn 44, Issue 2, 2005, Pages 154-160

  Nicodème, Frédéric ^a,b   Geffroy, Sandrine ^a   Conti, Massimo ^a   Delobel, Bruno ^c   Soenen, Valérie ^a,b   Grardel, Nathalie ^a,b   Porte, Henri ^a   Copin, Marie Christine ^a   Laï, Jean Luc ^a,b   Andrieux, Joris ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Institut de Recherche sur le Cancer de Lille   (France)

^c Groupement Hospitalier de L'Institut Catholique Facultél Libre de Méldecine de Lille   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; PROTEIN RAD51L1; RAD51 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CHROMOSOME 14Q; CHROMOSOME 20P; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; DNA RECOMBINATION; DNA REPAIR; DNA STRAND BREAKAGE; FAMILIAL DISEASE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAVES DISEASE; HAMARTOMA; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PANCYTOPENIA; PERNICIOUS ANEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SJOEGREN SYNDROME; TELOMERE; THYMOCYTE; THYMOMA; TUMOR SUPPRESSOR GENE; UTERUS MYOMA;

EID: 24944485227     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20225     Document Type: Article

References (53)

1. Abrams KL, Xu J, Nativelle-Serpentini C, Dabirshahsahebi S, Rogers MB. 2004. An evolutionary and molecular analysis of Bmp2 expression. J Biol Chem 279:15916-15928.
2. Amant F, Debiec-Rychter M, Schoenmakers EF, Hagemeijer-Hausman A, Vergote I. 2001. Cumulative dosage effect of a RAD51L1/ HMGA2 fusion and RAD51L1 loss in a case of pseudo-Meigs' syndrome. Genes Chromosomes Cancer 32:324-329.
3. Bergh NP, Gatzinsky P, Larsson S, Lundin P, Ridell B. 1978. Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. Ann Thorac Surg 25:91-98.
4. Blank C, Schoenmakers EF, Rogalla P, Huys EH, van Rijk AA, Drieschner N, Bullerdiek J. 2001. Intragenic breakpoint within RAD51L1 in a t(6;14)(p21.3;q24) of a pulmonary chondroid hamartoma. Cytogenet Cell Genet 95:17-19.
5. Blumberg D, Burt ME, Bains MS, Downey RJ, Martini N, Rusch V, Ginsberg RJ. 1998. Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg 115:303-308.
6. Dal Cin P, De Wolf-Peeters C, Aly MS, Deneffe G, Van Mieghem W, Van Den Berghe H. 1993. Ring chromosome 6 as the only change in a thymoma. Genes Chromosomes Cancer 6:243-244.
7. Dal Cin P, De Wolf-Peeters C, Deneffe G, Fryns JP, Van den Berghe H. 1996. Thymoma with a t(15;22)(p11;q11). Cancer Genet Cytogenet 89:181-183.
8. Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A, Lee EY. 1999. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 18:7883-7899.
9. Deminatti MM, Ribet M, Gosselin B, Bauters F, Mencier E, Savary JB, Lai JL, Vasseur F, Morel P, Bisiau-Leconte S. 1994. [Familial thymoma and translocation t(14;20)(q24;p13)]. Ann Genet 37:72-74.
10. Gobbi G, Sangiorgi L, Lenzi L, Casadei R, Canaider S, Strippoli P, Lucarelli E, Ghedini I, Donati D, Fabbri N, Warzecha J, Yeoung C, Helman LJ, Picci P, Carinci P. 2002. Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cells. Int J Oncol 20:143-147.
11. Goh SG, Lau LC, Sivaswaren C, Chuah KL, Tan PH, Lai D. 2001. Pseudodicentric (16;12)(q11;p11.2) in a type AB (mixed) thymoma. Cancer Genet Cytogenet 131:42-47.
12. Gomez-Santos C, Ambrosio S, Ventura F, Ferrer I, Reiriz J. 2002. TGF-beta1 increases tyrosine hydroxylase expression by a mechanism blocked by BMP-2 in human neuroblastoma SH-SY5Y cells. Brain Res 958:152-160.
13. Graf D, Nethisinghe S, Palmer DB, Fisher AG, Merkenschlager M. 2002. The developmentally regulated expression of Twisted gastrulation reveals a role for bone morphogenetic proteins in the control of T cell development. J Exp Med 196:163-171.
14. Hager-Theodorides AL, Outram SV, Shah DK, Sacedon R, Shrimpton RE, Vicente A, Varas A, Crompton T 2002. Bone morphogenetic protein 2/4 signaling regulates early thymocyte differentiation. J Immunol 169:5496-5504.
15. Herens C, Radermecker M, Servais A, Quatresooz P, Jardon-Jeghers C, Bours V, de Leval L. 2003. Deletion (6)(p22p25) is a recurrent anomaly of thymoma: report of a second case and review of the literature. Cancer Genet Cytogenet 146:66-69.
16. Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL. 2004. Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression. Prostate 59:234-242.
17. Ingraham SE, Lynch RA, Kathiresan S, Buckler AJ, Menon AG. 1999. hREC2, a RAD51-like gene, is disrupted by t(12;14) (q15;q24.1) in a uterine leiomyoma. Cancer Genet Cytogenet 115:56-61.
18. Inoue M, Fujii Y, Okumura M, Takeuchi Y, Shiono H, Miyoshi S, Matsuda H, Shirakura R. 1997. Mature CD4 single positive thymocytes in human Thymoma: T cells may differentiate in the thymic epithelial cell tumor. Pathobiology 65:216-222.
19. Inoue M, Marx A, Zettl A, Strobel P, Muller-Hermelink HK, Starostik P. 2002. Chromosome 6 suffers frequent and multiple aberrations in thymoma. Am J Pathol 161:1507-1513.
20. ISCN. 1995. An International System for Human Cytogenetic Nomenclature. Mitelman F, editor. Basel, Switzerland: S. Karger.
21. Jobard F, Bouadjar B, Caux F, Hadj-Rabia S, Has C, Matsuda F, Weissenbach J, Lathrop M, Prud'homme JF, Fischer J. 2003. Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome. Hum Mol Genet 12:925-935.
22. Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, Miyoshi T, Sakiyama S, Mukai K, Monden Y. 2004. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77:1183-1188.
23. Kristoffersson U, Heim S, Mandahl N, Akerman M, Mitelman F. 1989. Multiple clonal chromosome aberrations in two thymomas. Cancer Genet Cytogenet 41:93-98.
24. Kubonishi I, Takehara N, Iwaca J, Sonobe H, Ohtsuki Y, Abe T, Miyoshi I. 1991. Novel t(15;19)(ql5;pl3) chromosome abnormality in a thymic carcinoma. Cancer Res 51:3327-3328.
25. Langenfeld EM, Langenfeld J. 2004. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2:141-149.
26. Lee AC, Kwong YI, Fu KH, Chan GC, Ma L, Lau YL. 1993. Disseminated mediastinal carcinoma with chromosomal translocation (15;19). A distinctive clinicopathologic syndrome. Cancer 72: 2273-2276.
27. Marino M, Muller-Hermelink HK. 1985. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary diffetentiation of thymus. Virchows Arch A Pathol Anat Histopathol 407:119-149.
28. Masaoka A, Monden Y, Nakahara K, Tanioka T. 1981. Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485-2492.
29. Masson JY, Tarsounas MC, Stasiak AZ, Stasiak A, Shah R, McIlwraith MJ, Benson FE, West SC. 2001. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev 15:3296-3307.
30. Matani A, Dritsas C. 1973. Familial occurrence of thymoma. Arch Pathol 95:90-91.
31. Mirza I, Kazimi SN, Ligi R, Burns J, Braza F. 2000. Cytogenetic profile of a thymoma. A case report and review of the literature. Arch Pathol Lab Med 124:1714-1716.
32. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. 2002. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7:1191-1204.
33. Nakagawa K, Asamura H, Matsuno Y, Suzuki K, Kondo H, Maeshima A, Miyaoka E, Tsuchiya R. 2003. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 126:1134-1140.
34. Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A. 2002. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94:624-632.
35. Pascuzzi RM, Sermas A, Phillips LH 2nd, Johns TR. 1986. Familial autoimmune myasthenia gravis and thymoma: occurrence in two brothers. Neurology 36:423-427.
36. Peng L, Rice MC, Kmiec EB. 1998. Analysis of the human RAD51L1 promoter region and its activation by UV light. Genomics 54:529-541.
37. Rosai J, Levine G, Weber WR, Higa E. 1976. Carcinoid tumors and oat cell carcinomas of the thymus. Pathol Annu 11:201-226.
38. Rosai J. 1999. Histological typing of tumors of the thymus. WHO international histological classification of tumors. New York, NY: Springer Verlag.
39. Sait SN, Brooks JJ, Ashraf M, Zhang PJ. 2001. A novel t(1;8) (p13;p11) in a thymic carcinoma with unusual giant cell features and renal metastasis. Cancer Genet Cytogenet 124:140-143.
40. Sasaki H, Fujii Y, Ide N. 2003. Chromosome 6 abnormalities correlated with thymoma progression. Am J Pathol 163:2635-2636
41. Schluesener HJ, Meyermann R. 1991. TGF-beta 1, beta 2, beta 1.2 and the bone morphogenetic protein BMP2: members of the transforming growth factor type beta supergene family with different morphogenetic effects on rat astrocyte cultures. Autoimmunity 9:77-81.
42. Schoenmakers EF, Huysmans C, Van de Yen WJ. 1999. Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12:14) uterine leiomyomas. Cancer Res 59: 19-23.
43. Shields TW, Fox RT, Lees WM. 1966. Thymic tumors. Classification and treatment. Arch Surg 92:617-622.
44. Slowikowski J, Kubrakiewicz Z, Zielinski S. 1968. Giant hypertrophy of the thymus in three siblings. Pol Med J 7:634-637.
45. Sonobe H, Ohtsuki Y, Nakayama H, Asaba K, Nishiya K, Shimizu K. 1998. A thymic squamous cell carcinoma with complex chromosome abnormalities. Cancer Genet Cytogenet 103:83-85.
46. Sonobe H, Takeuchi T, Ohtsuki Y, Taguchi T, Shimizu K. 1999. A thymoma with clonal complex chromosome abnormalities. Cancer Genet Cytogenet 110:72-74.
47. Takahashi T, Nagai N, Oda H, Ohama K, Kamada N, Miyagawa K. 2001. Evidence for RAD51L1/HMGIC fusion in the pathogenesis of uterine leiomyoma, Genes Chromosomes Cancer 30:196-201.
48. Tsai PT, Lee RA, Wu H. 2003. BMP4 acts upstream of FGF in modulating thymic stroma and regulating thymopoiesis. Blood 102:3947-3953.
49. Vainio S, Karavanova I, Jowett A, Thesleff I. 1993. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 75:45-58.
50. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. 1988. Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534.
51. Wuketich S, Zwintz E. 1983. [Familial thymoma]. Wien Klin Wochenschr 95:424-428.
52. Zettl A, Strobel P, Wagner K, Katzenberger T, Ott G, Rosenwald A, Peters K, Krein A, Semik M, Muller-Hermelink HK, Marx A. 2000. Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 157:257-266.
53. Zou H, Niswander L. 1996. Requirement for BMP signaling in interdigital apoptosis and scale formation. Science 272:738-741.